Homologous recombination deficiency (HRD) represents a major area of research that is focused on demonstrating the utility and characterization of genomic scar analysis for implementation into routine care settings.
In this white paper you will learn:
- What is HRD?
- What are the efforts underway to harmonize HR status and its use as a biomarker in clinical research settings?
- What are the clinical research applications of HRD analysis and scoring?
- What are the challenges of HRD measurement and scoring?
- How is genomic scar analysis for HRD enabled through Bionano's NxClinical software?
Register to read more about genomic scar analysis for HRD with Bionano’s NxClinical analysis software.
